Abstract:R interference (RNAi) is a well-conserved mechanism that uses small noncoding RNAs to silence gene expression posttranscriptionally. Gene regulation by RNAi has been recognized as one of the major regulatory mechanisms in eukaryotic cells. Although the major components in RNAi/miRNA pathway have been identified, little is known about the regulation of the RNAi pathway itself. To dissect cellular components modulating RNAi using chemical biology approach, we have previously developed a cell-based assay to monitor the activity of the RNAi pathway. Several potent RNAi enhancers have been identified during the pilot screening from the 8,000 diversified compounds. Among them is a small-molecule enoxacin that enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. We show that this RNAi-enhancing activity depends on the trans-activation-responsive region RNA-binding protein. Our results provide a proof-of-principle demonstration that small molecules can be used to modulate the activity of the RNAi pathway and RNAi enhancers may be useful in the development of research tools and therapeutics. In addition to enoxacin, several other structurally distinct small molecules with metal/Fe chelating activity were found to significantly enhance RNAi activity as well in iron-dependent manner. Iron is essential for fundamental metabolic processes, and its homeostasis is tightly regulated. We show that cytosolic iron regulates the activity of the miRNA pathway through poly(C)-binding protein 2 (PCBP2). PCBP2 is associated with Dicer and promotes the processing of miRNA precursors. Cytosolic iron could modulate the association between PCBP2 and Dicer, as well as the dimerization of PCBP2 and its ability to bind to miRNA precursors, which can alter the processing of miRNA precursors. Our findings not only reveal an unexpected role for iron homeostasis in the regulation of miRNA biogenesis, but also suggest potential use of iron chelators to modulate the activity of the miRNA pathway.

E-cadherin Interacts With Posttranslationally-Modified AGO2 to Enhance miRISC Activity

Essential and Overlapping Functions for Mammalian Argonautes in Microrna Silencing.

An Argonaute Phosphorylation Cycle Promotes Microrna-Mediated Silencing

Mammalian Hyperplastic Discs Homolog Edd Regulates Mirna-Mediated Gene Silencing

Casein kinase 1 and 2 phosphorylate Argonaute proteins to regulate miRNA-mediated gene silencing

Eif1a Augments Ago2-mediated Dicer-independent Mirna Biogenesis and RNA Interference

Molecular Dynamics Simulations of Ago Silencing Complexes Reveal a Large Repertoire of Admissible 'Seed-Less' Targets.

GW182-Free microRNA Silencing Complex Controls Post-transcriptional Gene Expression during Caenorhabditis elegans Embryogenesis

Ago2/CAV1 interaction potentiates metastasis via controlling Ago2 localization and miRNA action

CSDE1 controls gene expression through the miRNA-mediated decay machinery

MicroRNA-Independent Modulation of DICER1 Expression by hAgo2

Elucidation of the Conformational Dynamics and Assembly of Argonaute–RNA Complexes by Distinct Yet Coordinated Actions of the Supplementary Microrna

AGO2 Phosphorylation by C-Src Kinase Promotes Tumorigenesis.

Argonaute 2 is a Key Regulator of Maternal Mrna Degradation in Mouse Early Embryos.

Modulation of Micro RNA/RNAi Pathway

Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics

Acetylation of AGO2 promotes cancer progression by increasing oncogenic miR-19b biogenesis

siRNA and miRNA: an insight into RISCs

Transcriptional Regulation of E-cadherin by Small Activating RNA: A New Double-Stranded RNA.

A Small Molecule Enhances RNA Interference and Promotes Microrna Processing

Interaction between a J-domain co-chaperone and a specific Argonaute protein contributes to microRNA function in animals